help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerbaud, P.
Right arrow Articles by Evain-Brion, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerbaud, P.
Right arrow Articles by Evain-Brion, D.

Endocrinology, Vol 129, 2530-2534, Copyright © 1991 by Endocrine Society

ARTICLES

Calcitonin and calcitonin gene-related peptide are chemotactic for F9 embryonal carcinoma cells

P Gerbaud, N Segond, MM Moukhtar and D Evain-Brion
Laboratoire de Physiopathologie du Developpement, CNRS URA 1337, ENS, Paris, France.

The chemotactic effect of calcitonin (CT) gene products was tested on F9 teratocarcinoma cells, which are an in vitro model of early embryonic development. CT and CT gene-related peptide (CGRP) induce a significant chemotactic response (chemotactic index, 40-50). The order of potency is: chicken CGRP greater than or equal to salmon CT greater than or equal to human CGRP. Human CT is a less potent chemotactic agent (chemotactic index, 15). Compared to other well known peptides with chemotactic activity, such as platelet-derived growth factor (no activity) and transforming growth factor-beta (chemotactic index, 5), CGRP and CT appear to be very active in attracting F9 cells in the Boyden chamber assay. Interestingly, CT and CGRP exhibit little chemotactic effect toward differentiated teratocarcinoma cells (i.e. retinoic acid-treated F9 cells or parietal endodermal PYS cells). While salmon CT and chicken CGRP activate adenylate cyclase activity in F9 cell membranes by 7- to 8-fold, higher concentrations (greater than 10(- 10) M) of these peptides are required to stimulate cAMP formation than are required to mediate the chemotactic effect of these peptides. These data imply the possible involvement of CT gene products in regulating cell migration during early embryonic development.


This article has been cited by other articles:


Home page
 Mol Hum ReprodHome page
K.E. Green, C. Thota, G.D.V. Hankins, C. Yallampalli, and Y.-L. Dong
Calcitonin gene-related peptide stimulates human villous trophoblast cell differentiation in vitro
Mol. Hum. Reprod., July 1, 2006; 12(7): 443 - 450.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Tsatsaris, A. Tarrade, P. Merviel, J. M. Garel, N. Segond, A. Jullienne, and D. Evain-Brion
Calcitonin Gene-Related Peptide (CGRP) and CGRP Receptor Expression at the Human Implantation Site
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4383 - 4390.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. M. Hutson, S. Hasthorpe, and C. F. Heyns
Anatomical and Functional Aspects of Testicular Descent and Cryptorchidism
Endocr. Rev., April 1, 1997; 18(2): 259 - 280.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society